Tickers — M

112 tickers
Ranks this page's recent reports by score.
Moody's Corporation
MCO·Financials
S ★★★★★Strong Buy
Current$488.83
Target$518.00
Return+6.0%
Oct 30, 2026

Moody's combines an entrenched credit-ratings moat with growing recurring financial analytics and exceptional cash generation, although cyclical debt issuance and demanding long-term valuation assumptions constrain near-term upside.

Score
89
MSC Industrial Direct Co., Inc.
MSM·Industrials
C ★★Sell
Current$113.86
Oct 26, 2026

MSC Industrial Direct offers a resilient industrial distribution franchise and improving adjusted margins, but demanding valuation, uneven cash conversion, and technology execution risks limit investment appeal.

Score
55
McDonald's Corporation
MCD·Consumer Discretionary
A ★★★★Buy
Current$248.46
Target$283.50
Return+14.1%
Oct 26, 2026

McDonald's combines a globally dominant franchise network, exceptional cash generation, and discounted historical valuation, but persistent U.S. traffic weakness and substantial modernization commitments could delay earnings recovery.

Score
80
MaxLinear, Inc.
MXL·Technology
B ★★★Hold
Current$63.46
Target$70.40
Return+10.9%
Oct 25, 2026

MaxLinear is gaining traction in high-speed AI data-center connectivity with accelerating revenue and improving margins, but demanding valuation, concentrated competition, and weak cash conversion constrain risk-adjusted upside.

Score
67
Medpace Holdings, Inc.
MEDP·Healthcare
B ★★★Hold
Current$669.20
Target$630.00
Return-5.9%
Oct 25, 2026

Medpace combines specialized clinical research expertise, high profitability, and strong cash generation with long-term outsourcing demand, but premium valuation and biotechnology funding sensitivity limit its near-term margin of safety.

Score
70
Mattel, Inc.
MAT·Consumer Discretionary
B ★★★Hold
Current$16.41
Target$18.62
Return+13.5%
Oct 24, 2026

Mattel's iconic toy franchises, discounted valuation, and strategic alternatives offer recovery potential, but weakening core-brand demand, margin pressure, and uncertain takeover outcomes constrain the investment case.

Score
74
Mueller Industries, Inc.
MLI·Industrials
A ★★★★Buy
Current$54.53
Target$61.50
Return+12.8%
Oct 23, 2026

Mueller combines exceptional capital efficiency, a fortress balance sheet, and growing infrastructure demand with attractive cash generation, although copper-price volatility and cyclical construction markets threaten margin durability.

Score
75
MSCI Inc.
MSCI·Financials
A ★★★★Buy
Current$620.52
Target$667.00
Return+7.5%
Oct 23, 2026

MSCI is a high-margin financial-data and index franchise capable of compounding recurring earnings through benchmark adoption and buybacks, although elevated leverage and premium valuation leave it exposed to market downturns.

Score
83
3M Company
MMM·Industrials
B ★★★Hold
Current$174.85
Target$184.30
Return+5.4%
Oct 23, 2026

3M's differentiated industrial portfolio and improving productivity support sustained earnings recovery, but elevated valuation and substantial litigation-related cash obligations constrain prospective shareholder returns.

Score
65
ManpowerGroup Inc.
MAN·Industrials
C ★★Sell
Current$41.22
Oct 20, 2026

ManpowerGroup offers cyclical recovery potential through its established global staffing franchise and discounted valuation, but weak free cash flow and uncertain profitability normalization undermine the investment case.

Score
55
Marsh & McLennan Companies, Inc.
MRSH·Financials
S ★★★★★Strong Buy
Current$188.50
Target$207.00
Return+9.8%
Oct 20, 2026

Marsh combines a durable global insurance brokerage moat, strong capital returns, and improving adjusted earnings at a historically attractive valuation, although insurance pricing weakness and persistent integration costs could limit upside.

Score
85
M&T Bank Corporation
MTB·Financials
B ★★★Hold
Current$215.28
Target$236.50
Return+9.9%
Oct 19, 2026

M&T Bank combines durable commercial relationships, solid profitability, and aggressive share repurchases with moderate earnings growth potential, but its elevated historical book-value multiple and sensitivity to funding costs constrain upside.

Score
69